ATE276276T1 - Rekombinanter anti-hiv antikörper und seine herstellung - Google Patents

Rekombinanter anti-hiv antikörper und seine herstellung

Info

Publication number
ATE276276T1
ATE276276T1 AT93901547T AT93901547T ATE276276T1 AT E276276 T1 ATE276276 T1 AT E276276T1 AT 93901547 T AT93901547 T AT 93901547T AT 93901547 T AT93901547 T AT 93901547T AT E276276 T1 ATE276276 T1 AT E276276T1
Authority
AT
Austria
Prior art keywords
antibody
hiv
codes
activity
human
Prior art date
Application number
AT93901547T
Other languages
English (en)
Inventor
Hiroaki Maeda
Kazuhiko Kimachi
Yasuyuki Eda
Kouichi Shiosaki
Kiyoshi Osatomi
Sachio Tokiyoshi
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE276276T1 publication Critical patent/ATE276276T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT93901547T 1993-01-14 1993-01-14 Rekombinanter anti-hiv antikörper und seine herstellung ATE276276T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002153165A CA2153165C (en) 1993-01-14 1993-01-14 Recombinant anti-hiv antibody and process for preparing the same
PCT/JP1993/000039 WO1994015969A1 (fr) 1993-01-14 1993-01-14 Anticorps anti-vih recombine et sa preparation

Publications (1)

Publication Number Publication Date
ATE276276T1 true ATE276276T1 (de) 2004-10-15

Family

ID=25678063

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93901547T ATE276276T1 (de) 1993-01-14 1993-01-14 Rekombinanter anti-hiv antikörper und seine herstellung

Country Status (10)

Country Link
US (1) US5773247A (de)
EP (1) EP0678523B1 (de)
AT (1) ATE276276T1 (de)
AU (1) AU671608B2 (de)
CA (1) CA2153165C (de)
DE (1) DE69333627T2 (de)
DK (1) DK0678523T3 (de)
ES (1) ES2229206T3 (de)
PT (1) PT678523E (de)
WO (1) WO1994015969A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399067B1 (en) * 2000-04-28 2002-06-04 Thymon L.L.C. Methods and compositions for impairing multiplication of HIV-1
US7090843B1 (en) 2000-11-28 2006-08-15 Seattle Genetics, Inc. Recombinant anti-CD30 antibodies and uses thereof
JP4347694B2 (ja) * 2001-10-16 2009-10-21 レイベン バイオテクノロジーズ，インコーポレイティド 癌関連抗原ｃｄ４６に結合する抗体およびその使用方法
CA2505633A1 (en) * 2002-11-13 2004-05-27 Raven Biotechnologies, Inc. Antigen pipa and antibodies that bind thereto
CN101213212A (zh) 2005-02-15 2008-07-02 西蒙有限公司 削弱hiv-1增殖的方法和组合物
KR101754433B1 (ko) * 2009-05-08 2017-07-05 백시넥스 인코포레이티드 항-ｃｄ100 항체 및 이의 사용 방법
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
CN102190726B (zh) * 2011-03-30 2013-03-27 中国医学科学院病原生物学研究所 一种人源HIV抗体的Fab片段及其编码基因与应用
CN102212133B (zh) * 2011-03-30 2013-01-16 中国医学科学院病原生物学研究所 人源HIV抗体的Fab片段及其编码基因与应用
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP2568289A3 (de) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunselektion von rekombinantem vesikulärem Stomatitisvirus mit Expression von HIV-1-Proteinen durch Breitbandneutralisierungs-Antikörper
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9925258B2 (en) 2015-10-02 2018-03-27 International Aids Vaccine Initiative Replication-competent VSV-HIV Env vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) * 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JP2646007B2 (ja) * 1988-01-30 1997-08-25 財団法人 化学及血清療法研究所 抗ｈｉｖ抗体可変領域をコードする遺伝子断片およびこれらを用いて発現された抗ｈｉｖキメラ抗体ならびにその製法
JP2989862B2 (ja) * 1990-07-02 1999-12-13 財団法人化学及血清療法研究所 モノクローナル抗体

Also Published As

Publication number Publication date
DE69333627D1 (de) 2004-10-21
WO1994015969A1 (fr) 1994-07-21
ES2229206T3 (es) 2005-04-16
AU3267193A (en) 1994-08-15
EP0678523A1 (de) 1995-10-25
CA2153165C (en) 2003-05-06
PT678523E (pt) 2004-12-31
US5773247A (en) 1998-06-30
AU671608B2 (en) 1996-09-05
DK0678523T3 (da) 2005-01-10
EP0678523A4 (de) 1998-08-05
CA2153165A1 (en) 1994-07-21
DE69333627T2 (de) 2005-09-22
EP0678523B1 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
ATE276276T1 (de) Rekombinanter anti-hiv antikörper und seine herstellung
DE69000338D1 (de) Expressionssystem zur herstellung von chimaeren monoklonalen antikoerpern.
EA200601715A1 (ru) Получение гуманизированных антител в [организме] трансгенных животных
ATE256751T1 (de) Monoklonaler anti-hiv antikörper
LTC0918797I2 (lt) Humanizuotas imunoglobulinas reaguojantis su alfa4beta7 integrinu
ATE122237T1 (de) Hiv-1 neutralisierende monoklonale antikörper.
ATE199745T1 (de) Rekombinanter antikörper gerichtet gegen das feline herpesvirus-1 und dafür kodierendes genfragment
DE3888425D1 (de) Virale Expressionsinhibitoren.
AR248044A1 (es) Una secuencia de adn que codifica anticuerpos monoclonales humanizados contra interleuquinas humanas, metodo de obtencion y de seleccion de dichos anticuerpos, vector recombinante y celula huesped.
GB8607679D0 (en) Recombinant dna product
IT8267522A0 (it) Procedimento per la produzione di dna complementare rappresentante sequenze virali di rna mediante metodi del dna ricombinante prodotti relativi e loro usi
SE8601325L (sv) Sett att producera ett immunglobulinbindande protein samt medel for detta
PT592836E (pt) Adn do local de integracao do virus adeno-associado humano e suas utilizacoes
JP2004528803A5 (de)
RU2004108115A (ru) Рекомбинантные антитела и композиции, а также способы их создания и использования
MX9301858A (es) Anticuerpos monoclonales neutralizantes de hiv-humano recombinante para prevencion y tratamiento de infeccion hiv.
DE69033987D1 (de) Katze-Maus-Heterohybridoma und Genfragment, das für die Konstant-Region von Katze-Immunoglobulin codiert
ATE119200T1 (de) Erhöhte produktion von proteinen in bakterien durch verwendung einer neuen ribosombindungsstelle.
GR3015892T3 (en) Virus resistant plants having a viral coat protein.
HUT63650A (en) Process for the modulation of gene expression by changing the secondary structure of rna
ATE337404T1 (de) Zur verleihung viraler resistenz an pflanzen geeignetes polyribozym und dieses polyribozym produzierende resistente pflanzen
EP0603672A3 (de) Verfahren zur Herstellung von rekombinanten und synthetischen Peptiden und deren Verwendung.
RU2018147193A (ru) Моноклональное антитело, способное нейтрализовать биологическую активность интерферона бета-1а человека
KR960700274A (ko) 재조합 항-hiv 항체 및 그의 제조방법[recombinant anti-hiv antibody and preparation thereof]

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0678523

Country of ref document: EP

REN Ceased due to non-payment of the annual fee